(P625, lat/long) | 41.4808 / 2.23782 |
hospital | Q16917 |
medical organization | Q4287745 |
P968 | email address | gerencia.germanstrias@gencat.net |
P2900 | fax number | +34-934-97-88-43 |
P2671 | Google Knowledge Graph ID | /g/121vxc2d |
P12385 | Gran Enciclopèdia Catalana ID | hospital-universitari-germans-trias-i-pujol |
P1296 | Gran Enciclopèdia Catalana ID (former scheme) | 0522827 |
P2427 | GRID ID | grid.411438.b |
P213 | ISNI | 0000000417676330 |
P856 | official website | http://www.gencat.cat/ics/germanstrias/ |
P402 | OpenStreetMap relation ID | 5678937 |
P1329 | phone number | +34-934-65-12-00 |
+34-934-97-88-12 | ||
P3500 | Ringgold ID | 16514 |
P6782 | ROR ID | 04wxdxa47 |
P8082 | Spanish National Catalog of Hospitals ID | 080667 |
080667 | ||
P11686 | University of Barcelona authority ID | 981058544799906706 |
P214 | VIAF ID | 129686021 |
P1416 | affiliation | Autonomous University of Barcelona | Q43452 |
P17 | country | Spain | Q29 |
P571 | inception | 1983-01-01 | |
P131 | located in the administrative territorial entity | Badalona | Q15468 |
P6801 | number of hospital beds | 516 | |
P137 | operator | Institut Català de la Salut | Q11926710 |
P749 | parent organization | Institut Català de la Salut | Q11926710 |
P580 | start time | 1983-04-14 | |
P6375 | street address | Cr Canyet, S/N |
FileName: Hospital Can Ruti.jpg
Description: Hospital Universitari Germans Trias i Pujol - Can Ruti.
Artist: Ottobdn
License: Public domain
Q90280294 | Adrià Plana Pla |
Q89772177 | Agusti Barnadas |
Q82622907 | Agusti Rodríguez-Palmero |
Q49238802 | Aintzane Urbizu |
Q86422160 | Alejandro Manzanares |
Q57076258 | Alessandro Catanese |
Q47158157 | Ana Lucía Arellano |
Q97549270 | Ana Merino Ribas |
Q57126614 | Andrea Colli |
Q64008860 | Ane Jaka |
Q57077202 | Antoni Matilla |
Q56251614 | Antonio Heras |
Q82657499 | Antonio Rodríguez-D'Jesús |
Q50533133 | Aram Boada |
Q91514105 | Ariadna Pérez-Ricart |
Q88449395 | Carles Subirà |
Q93193895 | Carlos Castaño Duque |
Q92029762 | Carlos Puig-Jové |
Q53179123 | Carlos Rodrigo |
Q60655490 | Carmen Biosca |
Q92090133 | Cesc Bertran-Cobo |
Q79268207 | Cosme Garcia Garcia |
Q87734050 | Cristian Carrasco-López |
Q41531275 | Cristian Tebé |
Q82998283 | Cristina Ibanez Esteves |
Q51034795 | Cristina Ramo-Tello |
Q73342460 | Daniel Escuin |
Q57016359 | Daniel Fuster |
Q56956489 | David Parés |
Q30362226 | Didac Mauricio |
Q58327339 | Dolores Álamo-Junquera |
Q58283738 | Domingo Escudero |
Q92589861 | Eduard Fernandez Nofrerías |
Q87072219 | Eduard Pedemonte-Sarrias |
Q41830346 | Elisabeth Castellanos |
Q82292745 | Emma García-Melchor |
Q62123867 | Esteban Reynaga |
Q57416397 | Eva Martínez-Balibrea |
Q50280630 | Eva Martínez-Cáceres |
Q38798935 | Eva Montané |
Q82563066 | Fernando Arméstar |
Q100546827 | Ferran Rueda |
Q64005420 | Giuseppe Lucente |
Q55718159 | Guillem Pintos-Morell |
Q84594414 | Helena Collgros |
Q98574144 | Iara Da Silva |
Q37378421 | Ignacio Blanco |
Q94523888 | Ignasi Camps Ausàs |
Q57161192 | Inés Velasco |
Q89834193 | Irene Aldás |
Q99610325 | Irene Espallargas |
Q40808679 | Irene Latorre |
Q100959278 | Ivan Hurtado |
Q49832086 | Jaume Barallat |
Q92288362 | Javier Corral |
Q90944970 | Jesús Ribas |
Q38546550 | Joan Carles Galcerán |
Q67265581 | Joan Francesc Julián Ibañez |
Q67558237 | Joan Verdaguer Autonell |
Q104745457 | Jordi Bover |
Q86187420 | Jose Vicente Hervas-Garcia |
Q41691826 | Josep Lupón |
Q37393125 | Josep M. Llovet |
Q91596295 | José A Hernández-Hermoso |
Q50202660 | José M. Balibrea |
Q87734695 | José Manuel Carrascosa |
Q55948645 | José Moltó |
Q86484536 | Juan Colán-Hernández |
Q88536024 | Juan José López |
Q92023107 | Juan José Zamora-Sánchez |
Q63924088 | Juan Luis Becerra |
Q79682088 | Juan Manuel Leyva Moral |
Q87413710 | Julia Canet-Pons |
Q60315981 | Laia Gifre |
Q98385273 | Laura Blanco |
Q91795359 | Laura Soldevila |
Q90433107 | Lidia Blay |
Q63768173 | Lourdes Mateu |
Q41090446 | Lílliam Flores |
Q89298133 | Magí Farré |
Q57338194 | Manuel Armengol |
Q60533273 | Manuel Canal-Rivero |
Q44011983 | Manuel Gómez-Choco |
Q57571503 | Marc Sorigue |
Q59667218 | Maria A Llopis |
Q92180178 | Maria Bonjorn Juarez |
Q104607290 | Maria Doladé |
Q98187335 | Maria-Luisa Granada |
Q89059933 | Mariusz Łucejko |
Q101220609 | María Aparicio Espinar |
Q57158302 | María Iglesias-González |
Q90227743 | Max Hardy-Werbin |
Q101220618 | Melania Martinez Morillo |
Q100506281 | Miquel Gil Olaria |
Q94462974 | Montserrat Guasch |
Q90126924 | Montserrat Rovira Argelagués |
Q88418452 | Míriam Mañosa Ciria |
Q102217869 | Napoleón de la Ossa |
Q24291756 | Oriol Mitjà Villar |
Q114337191 | Oscar-Danilo Ortega-Hernandez |
Q92154093 | Paloma Malagón-López |
Q79898650 | Paloma Puyalto |
Q90969786 | Patricia Echeverría |
Q89275612 | Pedro Moliner-Borja |
Q85371439 | Pere Vila Caral |
Q16187422 | Pere-Joan Cardona i Iglesias |
Q96247202 | Pilar Aparicio |
Q88474875 | Ramiro Álvarez |
Q57039309 | Ramon Romero |
Q58878872 | Raquel Villar-Hernández |
Q64706155 | Rosa Garcia Sanchez |
Q55135625 | Ross D Cranston |
Q83681398 | Samuel García-Reina |
Q91793678 | Sandra Bonache |
Q97433299 | Santiago Montero |
Q98200344 | Sebastián Remollo |
Q91208776 | Sergio Alonso-Fernández |
Q98388608 | Sergio Marin |
Q92153022 | Silvia Maya-Enero |
Q98619071 | Silvia Reverté-Villarroya |
Q87857146 | Sonia Sevilla Guerra |
Q82886134 | Susana Santos-Ruiz |
Q87642425 | Susanna Gassiot |
Q89087477 | Sílvia Roure |
Q59683393 | Vicente Ausina |
Q42120755 | Vicente Lorenzo-Zúñiga |
Q82051456 | Xavier Carrillo |
Q82622907 | Agusti Rodríguez-Palmero |
Q92842032 | Alicia Garrido |
Q47158157 | Ana Lucía Arellano |
Q61767885 | Ana Marín-Sánchez |
Q60655490 | Carmen Biosca |
Q51034795 | Cristina Ramo-Tello |
Q82292745 | Emma García-Melchor |
Q62123867 | Esteban Reynaga |
Q49832086 | Jaume Barallat |
Q56939544 | Jaume Coll-Cantí |
Q86187420 | Jose Vicente Hervas-Garcia |
Q81101074 | José Luís Cuadra Urteaga |
Q87837047 | Lorena Martín-Aguilar |
Q57571503 | Marc Sorigue |
Q71943825 | Merce Avellanet |
Q90126924 | Montserrat Rovira Argelagués |
Q102217869 | Napoleón de la Ossa |
Q92154093 | Paloma Malagón-López |
Q16187422 | Pere-Joan Cardona i Iglesias |
Q88474875 | Ramiro Álvarez |
Q89916152 | Robert Cilveti |
Q74349921 | Sebastià J. Santaeugenia |
Q98200344 | Sebastián Remollo |
Q42120755 | Vicente Lorenzo-Zúñiga |
Q55664892 | Xavier Soria |
Q62104815 | "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects |
Q64794595 | A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) |
Q63811701 | A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) |
Q64220493 | A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM) |
Q65364903 | A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects |
Q64353535 | A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer |
Q63320509 | A Phase IIa Study of NT-KO-003 for Multiple Sclerosis |
Q66082259 | A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease |
Q62811890 | A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety |
Q64638737 | A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib |
Q63572072 | A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) |
Q65364969 | A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication |
Q63811891 | A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis |
Q63811716 | A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) |
Q63592443 | A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy |
Q64715171 | A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy |
Q65474364 | Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection |
Q63315792 | Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease |
Q64139511 | Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy |
Q64710673 | Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning |
Q66038405 | Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor |
Q66038404 | Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART |
Q64607189 | An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT) |
Q63807993 | An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s) |
Q64599278 | Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer |
Q64623223 | Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations |
Q63832484 | Anticoagulation in Stent Intervention |
Q61918239 | Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome |
Q64635797 | Aspergillus PCR Early Detection in High Risk Oncohematological Patients |
Q63316083 | Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants |
Q66039461 | Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) |
Q61981025 | Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma |
Q63812630 | Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma |
Q65379596 | Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line Treatment in Postmenopausal Patients With Advanced or Metastatic Breast Cancer |
Q63573813 | Bowel Preparation for Repeat Colonoscopy After Preparation Failure (RepeatPrep Study) |
Q65539969 | Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer |
Q65363116 | Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) |
Q66082293 | Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain |
Q64648084 | Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 Years |
Q61956389 | Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) |
Q64646942 | Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer |
Q64646565 | Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D |
Q62811342 | Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic |
Q64614208 | Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen |
Q65379397 | Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers |
Q64817491 | Clinical and Molecular Staging of Lung Cancer Stages I and IIp |
Q63811512 | Comparative Study Between Conventional and Telematic Patients Follow-up |
Q62031616 | Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR |
Q65368213 | Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase |
Q65474298 | Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma |
Q64599156 | Diet for Colonoscopy Preparation in Diabetic Patients |
Q65351761 | Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC |
Q63335700 | Drug Interactions Between Echinacea Purpurea and Etravirine |
Q64678486 | EMERALD - AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients |
Q66067043 | Effectiveness and Cost-Effectiveness Study of Medical Nutrition in Malnourished Patients in Spain |
Q64715386 | Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism |
Q65473310 | Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) |
Q64042471 | Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis |
Q65471177 | Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy |
Q64354982 | Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. |
Q62054729 | Efficacy and Safety of a Simplification Treatment Based on Dolutegravir and Darunavir / Cobicistat vs Usual Treatment in Suppressed HIV-1-infected Patients With Multidrug Resistance. |
Q64654934 | Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period |
Q64697448 | Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine |
Q63600002 | Efficacy of a Smartphone App for Chronic Pain Management |
Q64640824 | Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours |
Q65348854 | Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults |
Q64697523 | Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne |
Q66030728 | FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients |
Q61918213 | Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia |
Q65474208 | Glivec in Ph Positive Lymphoblastic Leukemia |
Q63400918 | Global Post-market Registry for the Treovance Stent-graft. |
Q64719335 | HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain |
Q65377501 | High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 |
Q61955738 | Home Telehealth Follow-up After Hospital Discharge for Chronic Obstructive Pulmonary Disease (COPD) Patients |
Q63812335 | INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer |
Q64720918 | Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV |
Q65380740 | Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression |
Q64598035 | Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients |
Q64660548 | Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination |
Q65355221 | Individualized Perioperative Open Lung Ventilatory Strategy |
Q66042288 | Individualized Perioperative Open-Lung Ventilatory Strategy During One-Lung Ventilation |
Q64602660 | Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance |
Q64651544 | LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML) |
Q64652090 | Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed |
Q105493630 | Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler |
Q64649688 | Maraviroc Switch Collaborative Study |
Q65384017 | Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation |
Q64664387 | Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent |
Q64123777 | Multicentre Registry of Patients With Spontaneous Acute Intracerebral Hemorrhage in Catalonia (HIC-CAT). |
Q63572991 | Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer |
Q65365394 | Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin |
Q63399245 | Nordic and Spanish Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chronic Total Coronary Occlusions With Myocardial Ischemia |
Q65387716 | OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer |
Q61966184 | Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation |
Q63336106 | PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years |
Q61917621 | PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia |
Q64150211 | PH3 Study of Mirvetuximab Soravtansine vs Investigator's Choice of Chemotherapy in Women With FRa+ Adv. EOC, Primary Peritoneal or Fallopian Tube Cancer |
Q66063177 | PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation |
Q64625185 | Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study) |
Q63402264 | Parsaclisib in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112) |
Q65471056 | Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens |
Q64836727 | Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC |
Q63831268 | Perioperative Management of Patients With Coronary Stents Undergoing Noncardiac Surgery |
Q64139628 | Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia |
Q64354109 | Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma |
Q64694268 | Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. |
Q64718692 | Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study |
Q64794119 | Physiotherapy and Therapeutic Education on Patients With Pain Catastrophism Scheduled for a Total Knee Arthroplasty |
Q64662036 | Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV |
Q63578810 | Population-based Study in Screening for Liver Fibrosis |
Q65465905 | Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder |
Q63397892 | Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study |
Q64602638 | Pulmonary Embolism as a Cause of COPD Exacerbations |
Q65382109 | QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression |
Q64655089 | R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial |
Q63403760 | Respiratory Microbiome and COPD Exacerbations (RESMECOPD) |
Q64351601 | Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs |
Q65373877 | Risk-adapted Therapy for Adult Acute Myeloid Leukemia. |
Q61917558 | SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome |
Q61918327 | SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia |
Q61980007 | Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02) |
Q66078728 | Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children |
Q63575010 | Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer |
Q63812466 | Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease |
Q66032710 | Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) |
Q63320259 | Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT. |
Q65470447 | Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments |
Q64188156 | Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors |
Q64795782 | Spanish Cohort of Patients With HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function |
Q61907088 | Spanish Registry on Spontaneous Coronary Artery Dissection |
Q64675336 | Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) |
Q65356334 | Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL |
Q64790062 | Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis |
Q61939192 | Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects |
Q63830391 | Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) |
Q65376625 | Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure |
Q66039972 | Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects |
Q64651888 | Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma |
Q63575505 | Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors |
Q66074490 | Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice |
Q106638192 | Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children |
Q63316079 | Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL |
Q63818648 | Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF |
Q63320949 | Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically S |
Q107169691 | Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir. |
Q65331125 | Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues |
Q96759577 | Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19) |
Q65348661 | Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disop |
Q66039776 | T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs |
Q64718528 | TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer. |
Q65377677 | TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer |
Q63582877 | Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock |
Q65387141 | The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus |
Q61936877 | Third International Study on Mechanical Ventilation |
Q63811776 | This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms. |
Q63811774 | This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms |
Q106975759 | To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) (2021-06-30) |
Q64353239 | Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma |
Q64693789 | Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients |
Q65379371 | Treatment Insulin Resistence in HCV G-1 Patient |
Q63319090 | Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS |
Q65473806 | Treatment of Acute Myeloblastic Leukemia in Younger Patients |
Q61981020 | Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r |
Q64139680 | Treatment of High Risk Adult Acute Lymphoblastic Leukemia |
Q65472914 | Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) |
Q61980044 | Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) |
Q65382930 | Trial of Dacarbazine With or Without Genasense in Advanced Melanoma |
Q64724117 | Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV |
Q65363191 | Urban Training for COPD Patients |
Q65473704 | VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma |
Q65355512 | Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies |
Q66047412 | Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib |
Q65474257 | Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients. |
Q64170787 | Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) |
Q64720375 | ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®) |
Q106138919 | sFlt1/PlGF and Selective Labor Induction to Prevent Preeclampsia at Term |
Q30287739 | Germans Trias i Pujol Research Institute | headquarters location | P159 |
Q30254599 | IrsiCaixa | location | P276 |
Q11926710 | Institut Català de la Salut | has subsidiary | P355 |
Q65157062 | Manuel Ribas Mundó | work location | P937 |